STATE STREET CORP - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$66,400
+80.1%
222,8190.0%0.00%
Q2 2023$36,877
-83.1%
222,819
-0.5%
0.00%
Q1 2023$218,457
-49.8%
223,829
-46.5%
0.00%
Q4 2022$435,404
+80.7%
418,658
+100.0%
0.00%
Q3 2022$241,000
-38.4%
209,3290.0%0.00%
Q2 2022$391,000
-39.6%
209,329
-2.0%
0.00%
Q1 2022$647,000
-9.6%
213,499
+12.7%
0.00%
Q4 2021$716,000
-26.9%
189,3870.0%0.00%
Q3 2021$979,000
+50.4%
189,387
+11.3%
0.00%
Q2 2021$651,000
-72.4%
170,087
-81.5%
0.00%
Q1 2021$2,357,0000.0%917,247
-2.7%
0.00%
Q4 2020$2,357,000
+23.2%
942,822
+2.0%
0.00%
Q3 2020$1,913,000
-33.1%
924,369
+0.1%
0.00%
Q2 2020$2,861,000
+35.3%
923,058
-0.4%
0.00%
Q1 2020$2,114,000
-40.8%
927,220
-6.0%
0.00%
Q4 2019$3,572,000
+7.9%
986,703
+1.6%
0.00%
Q3 2019$3,312,000
-31.2%
971,245
-5.1%
0.00%
Q2 2019$4,812,000
+56.8%
1,023,895
+11.8%
0.00%
Q1 2019$3,068,000
+27.3%
915,915
+1.0%
0.00%
Q4 2018$2,411,000
-52.6%
906,570
-0.3%
0.00%
Q3 2018$5,090,000
+34.2%
909,144
+21.7%
0.00%
Q2 2018$3,792,000
-4.9%
747,250
+27.8%
0.00%
Q1 2018$3,987,000
-0.6%
584,649
+10.0%
0.00%
Q4 2017$4,012,000
+34.7%
531,516
+2.8%
0.00%
Q3 2017$2,978,000
+25.3%
517,052
+10.1%
0.00%
Q2 2017$2,377,000469,6520.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,136,319$3,443,0003.20%
Aquilo Capital Management, LLC 3,708,882$11,238,0001.65%
Soleus Capital Management, L.P. 4,134,868$12,529,0001.62%
GREAT POINT PARTNERS LLC 2,199,076$6,663,0001.61%
BVF INC/IL 5,328,239$16,145,0000.65%
Cutter & CO Brokerage, Inc. 406,229$1,231,0000.37%
WEALTH EFFECTS LLC 80,400$244,0000.11%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$3,116,0000.10%
Rhenman & Partners Asset Management AB 300,000$909,0000.09%
Woodline Partners LP 1,587,475$4,810,0000.08%
View complete list of PIERIS PHARMACEUTICALS INC shareholders